Belpointe Asset Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-3,049
Closed -$71.5K – 1642
2023
Q1
$71.5K Buy
3,049
+761
+33% +$21.7K ﹤0.01% 1495
2022
Q4
$62.2K Buy
+2,288
New +$105K ﹤0.01% 1483

Other funds holding GH

Belpointe Asset Management's GH Position: Q2 2023 in Review

Belpointe Asset Management sold out of Guardant Health (GH) in Q2 2023, closing a stake of 3,049 shares — an estimated $71.5K sold.

Belpointe Asset Management first reported a position in GH in Q4 2022 and held it in 2 quarters. The position peaked at $71.5K in Q1 2023. 299 funds tracked by Wall St. Rank hold GH as of Q2 2023.

  • Belpointe Asset Management reported no remaining Guardant Health position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 3,049 Guardant Health shares in Q2 2023, an estimated $71.5K.
  • Belpointe Asset Management first reported a position in Guardant Health in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's Guardant Health position peaked at $71.5K in Q1 2023.
  • 299 funds tracked by Wall St. Rank held Guardant Health as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.